Nanyang Pukang Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLINDAMYCIN HYDROCHLORIDE, with a corresponding US DMF Number 20971.
Remarkably, this DMF maintains an Active status since its submission on October 25, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 26, 2014, and payment made on September 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II